Sonoma Pharmaceuticals, Inc. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Sonoma Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Sonoma Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -26 %, a 36.9% increase year-over-year.
  • Sonoma Pharmaceuticals, Inc. annual Return On Assets for 2023 was -31.1 %, a 8.72% decline from 2022.
  • Sonoma Pharmaceuticals, Inc. annual Return On Assets for 2022 was -28.6 %, a 2.49% increase from 2021.
  • Sonoma Pharmaceuticals, Inc. annual Return On Assets for 2021 was -29.3 %, a 18.9% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -31.1 -2.49 -8.72% Apr 1, 2023 Mar 31, 2024
2022 -28.6 +0.73 +2.49% Apr 1, 2022 Mar 31, 2023
2021 -29.3 -4.65 -18.9% Apr 1, 2021 Mar 31, 2022
2020 -24.6 -3.46 -16.3% Apr 1, 2020 Mar 31, 2021
2019 -21.2 +37.7 +64% Apr 1, 2019 Mar 31, 2020
2018 -58.9 +19.1 +24.5% Apr 1, 2018 Mar 31, 2019
2017 -78 -147 -213% Apr 1, 2017 Mar 31, 2018
2016 69.1 +131 Apr 1, 2016 Mar 31, 2017
2015 -62.4 +3.11 +4.75% Apr 1, 2015 Mar 31, 2016
2014 -65.5 -97 -308% Apr 1, 2014 Mar 31, 2015
2013 31.5 +95.8 Apr 1, 2013 Mar 31, 2014
2012 -64.3 Apr 1, 2012 Mar 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.